Kodiak Sciences (KOD) Long-Term Debt Issuances (2018)

Kodiak Sciences (KOD) posted Long-Term Debt Issuances of $33.0 million for Q1 2018.

Kodiak Sciences (KOD) Long-Term Debt Issuances (2018) Analysis & Trends

Kodiak Sciences' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at $33.0 million for Q1 2018.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $33.0 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $33.0 million (changed N/A YoY) and the FY2018 annual result came in at $33.0 million, up 230.0% from the prior year.
Long-Term Debt Issuances was $33.0 million for Q1 2018 at Kodiak Sciences.
Across five years, Long-Term Debt Issuances topped out at $33.0 million in Q1 2018 and bottomed at $33.0 million in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Kodiak Sciences	2.54 Bn	2.54 Bn	-	-

Download Data

Date	Value
Mar 31, 2018	33.00 Mn
Mar 31, 2018	33.00 Mn